Review



az11645373  (Tocris)


Bioz Verified Symbol Tocris is a verified supplier
Bioz Manufacturer Symbol Tocris manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 92

    Structured Review

    Tocris az11645373
    Az11645373, supplied by Tocris, used in various techniques. Bioz Stars score: 92/100, based on 34 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/az+11645373/AZ+11645373/pm39225832-59-0-4
    Average 92 stars, based on 34 article reviews
    az11645373 - by Bioz Stars, 2026-10
    92/100 stars

    Images

    Related Articles

    other:

    Article Title: Cigarette smoke induces overexpression of active human cathepsin S in lungs from current smokers with or without COPD.
    Article Snippet: 343 344 Treament of pHBECs with P2X7 antagonist: Confluent pHBECs were pre-incubated with AZ 345 11645373, a highly specific P2X7 antagonist (1 μM, Tocris Bioscience) or mock (DMSO) for 346 1 h, before exposure for 2 h to 2.5 % CSE.

    Article Title: Lipopolysaccharide-Mediated Induction of Concurrent IL-1β and IL-23 Expression in THP-1 Cells Exhibits Differential Requirements for Caspase-1 and Cathepsin B Activity.
    Article Snippet: The inflammasome is a multimeric protein complex required for interleukin (IL)-1b production.. Upon lipopolysaccharide (LPS) triggering of toll-like receptor (TLR)-4 and subsequent ATP signaling, the NOD-like receptor containing-pyrin domain 3 (NLRP3) inflammasome is activated to cleave pro-caspase-1 into caspase-1, allowing the secretion of IL-1b.. IL-1b is known to function with IL-23 in the regulation of IL-17-producing CD4 T cells, Th17 cells, in adaptive immunity.

    Article Title: Method for treatment of macular degeneration by modulating P2Y12 or P2X7 receptors
    Article Snippet: Other known compositions that are also useful to inhibit the P2X7 receptors (antagonists for the P2X7 receptor), e.g., A740003 (18/40 nM), AZ-10606120 (19/1.4 nM), AZ-11645373 (6 nM human), KN-62 (15 nM human), A-839977, A-74003, NF279, MRS 2159, all commercially available from Tocris; A-847227 available from Abbott Laboratories (Abbott Park, Ill.); GSK314181A available from GalaxoSmithKline Pharmaceuticals (Middlesex, United Kingdom); AZD-9056 available from AstraZeneca (Wilmington, Del.); CE-224535 available from Pfizer, Inc. (New York, N.Y.); AF-4025 and AFC-5128, available from Affectis Pharmaceuticals AG (Martinsried, Germany); EVT 401 available from Evotec (Hamburg, Germany); and MRS2306 and MRS2540 available from the National Institutes of Health (NIH, Rockville, Md.).

    Article Title: Cigarette smoke induces overexpression of active human cathepsin S in lungs from current smokers with or without COPD.
    Article Snippet: AZ 11645373) came from Tocris Bioscience 161 (Bristol, UK).

    Article Title: P2X7Rs are involved in cell death, growth and cellular signaling in primary human osteoblasts.
    Article Snippet: P2X7Rs are involved in cell death, growth and cellular signaling in primary human osteoblasts Ankita Agrawal, Zanne Henriksen, Susanne Syberg, Solveig Petersen, Derya Aslan, Marie Solgaard, Nis Nissen, Tommy Korsgaard Larsen, Peter Schwarz, Thomas H. Steinberg, Niklas Rye Jørgensen PII: S8756-3282(16)30344-1 DOI: doi: 10.1016/j.bone.2016.11.011 Reference: BON 11183 To appear in: Bone Received date: 8 August 2016 Revised date: 10 November 2016 Accepted date: 11 November 2016 Please cite this article as: Agrawal Ankita, Henriksen Zanne, Syberg Susanne, Petersen Solveig, Aslan Derya, Solgaard Marie, Nissen Nis, Larsen Tommy Korsgaard, Schwarz Peter, Steinberg Thomas H., Jørgensen Niklas Rye, P2X7Rs are involved in cell death, growth and cellular signaling in primary human osteoblasts, Bone (2016), doi: 10.1016/j.bone.2016.11.011 This is a PDF file of an unedited manuscript that has been accepted for publication.. As a service to our customers we are providing this early version of the manuscript.. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form.




    Similar Products

    92
    Tocris az11645373
    Az11645373, supplied by Tocris, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/az+11645373/AZ+11645373/pm39225832-59-0-4
    Average 92 stars, based on 1 article reviews
    az11645373 - by Bioz Stars, 2026-10
    92/100 stars
      Buy from Supplier

    92
    Alomone Labs az 11645373
    Az 11645373, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/az+11645373/AZ11645373/pmc10855801-148-58-59
    Average 92 stars, based on 1 article reviews
    az 11645373 - by Bioz Stars, 2026-10
    92/100 stars
      Buy from Supplier

    92
    Tocris nitro 1 1 biphenyl 4 yl oxy methyl
    Nitro 1 1 Biphenyl 4 Yl Oxy Methyl, supplied by Tocris, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/az+11645373/AZ+11645373/pmc07312811-182-1-7
    Average 92 stars, based on 1 article reviews
    nitro 1 1 biphenyl 4 yl oxy methyl - by Bioz Stars, 2026-10
    92/100 stars
      Buy from Supplier

    92
    Tocris az 11645373
    Az 11645373, supplied by Tocris, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/az+11645373/AZ+11645373/pm31553637-65-0-4
    Average 92 stars, based on 1 article reviews
    az 11645373 - by Bioz Stars, 2026-10
    92/100 stars
      Buy from Supplier

    92
    R&D Systems p2x7 receptor antagonist az11645373
    Figure 3. ATP-induced IL-6 production in SSc fibroblasts was mediated primarily via purinergic P2Y2 receptor. (a) IL-6 mRNA in SSc fibroblasts treated with ATP and/or nonselective P2 receptor antagonist suramin for 1 hour. (b) IL-6 mRNA in SSc fibroblasts treated with ATP and/or P2X4 receptor antagonist 5-BDBD, <t>P2X7</t> receptor antagonist <t>AZ11645373,</t> P2Y1 receptor antagonist MRS2179, P2Y2 receptor antagonist AR-C118925XX, P2Y11 receptor antagonist NF157, P2Y12 receptor antagonist clopidogrel, and P2Y14 receptor antagonist PPTN for 1 hour. (c) IL-6 mRNA in SSc fibroblasts treated with ATP and/or P2Y2 receptor antagonist, kaempferol for 1 hour. n ¼ 3 patients. mRNA levels in fibroblasts without treatments were assigned a value of 1. All values represent mean standard error of the mean. *P < 0.05, **P < 0.01. ATP, adenosine triphosphate; SSc, systemic sclerosis.
    P2x7 Receptor Antagonist Az11645373, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/az+11645373/AZ+11645373/pm30404019-169-26-32
    Average 92 stars, based on 1 article reviews
    p2x7 receptor antagonist az11645373 - by Bioz Stars, 2026-10
    92/100 stars
      Buy from Supplier

    Image Search Results


    Figure 3. ATP-induced IL-6 production in SSc fibroblasts was mediated primarily via purinergic P2Y2 receptor. (a) IL-6 mRNA in SSc fibroblasts treated with ATP and/or nonselective P2 receptor antagonist suramin for 1 hour. (b) IL-6 mRNA in SSc fibroblasts treated with ATP and/or P2X4 receptor antagonist 5-BDBD, P2X7 receptor antagonist AZ11645373, P2Y1 receptor antagonist MRS2179, P2Y2 receptor antagonist AR-C118925XX, P2Y11 receptor antagonist NF157, P2Y12 receptor antagonist clopidogrel, and P2Y14 receptor antagonist PPTN for 1 hour. (c) IL-6 mRNA in SSc fibroblasts treated with ATP and/or P2Y2 receptor antagonist, kaempferol for 1 hour. n ¼ 3 patients. mRNA levels in fibroblasts without treatments were assigned a value of 1. All values represent mean standard error of the mean. *P < 0.05, **P < 0.01. ATP, adenosine triphosphate; SSc, systemic sclerosis.

    Journal: The Journal of investigative dermatology

    Article Title: The Regulation of Skin Fibrosis in Systemic Sclerosis by Extracellular ATP via P2Y 2 Purinergic Receptor.

    doi: 10.1016/j.jid.2018.10.027

    Figure Lengend Snippet: Figure 3. ATP-induced IL-6 production in SSc fibroblasts was mediated primarily via purinergic P2Y2 receptor. (a) IL-6 mRNA in SSc fibroblasts treated with ATP and/or nonselective P2 receptor antagonist suramin for 1 hour. (b) IL-6 mRNA in SSc fibroblasts treated with ATP and/or P2X4 receptor antagonist 5-BDBD, P2X7 receptor antagonist AZ11645373, P2Y1 receptor antagonist MRS2179, P2Y2 receptor antagonist AR-C118925XX, P2Y11 receptor antagonist NF157, P2Y12 receptor antagonist clopidogrel, and P2Y14 receptor antagonist PPTN for 1 hour. (c) IL-6 mRNA in SSc fibroblasts treated with ATP and/or P2Y2 receptor antagonist, kaempferol for 1 hour. n ¼ 3 patients. mRNA levels in fibroblasts without treatments were assigned a value of 1. All values represent mean standard error of the mean. *P < 0.05, **P < 0.01. ATP, adenosine triphosphate; SSc, systemic sclerosis.

    Article Snippet: Cells were pretreated with the nonselective P2 receptor antagonist suramin (100 mmol/L; SigmaAldrich, St. Louis, MO), P2X4 receptor antagonist 5-BDBD (100 mmol/L; Tocris Bioscience, Bristol, UK), P2X7 receptor antagonist AZ11645373 (1 mmol/L; R&D Systems, Minneapolis, MN), P2Y1 receptor antagonist MRS2179 (100 mmol/L, Tocris Bioscience), P2Y2 receptor antagonists AR-C118925XX (10 mmol/L, Tocris Bioscience) and kaempferol (30 mmol/L, Sigma-Aldrich), P2Y11 receptor antagonist NF157 (50 mmol/L, Tocris Bioscience), P2Y12 receptor antagonist clopidogrel (30 mmol/L, Tokyo Chemical Industry, Tokyo, Japan), P2Y14 receptor antagonist PPTN hydrochloride (1 mmol/L, Tocris Bioscience), p38 inhibitor SB203580 (10 mmol/L, Wako), and BIRB796 (10 mmol/L; AdooQ Bioscience, Irvine, CA) for 30 minutes and then stimulated with 1 mmol/L ATP for 1 hour.

    Techniques: